Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy.

Ariadna PérezJuan MontoroPedro ChorãoDolores GómezManuel GuerreiroEstela GiménezMarta VillalbaJaime SanzRafael HernaniJuan Carlos Hernández-BoludaIgnacio LorenzoDavid NavarroCarlos SolanoPer LjungmanJosé Luis Piñana

Published in: Infection (2024)

ALC, corticosteroids, and fever increased the risk for progression to LRTD while ribavirin decreased the risk. However, mortality was associated with ALC and co-infections. This study supports further research of ribavirin therapy for hPIV in the allo-HSCT setting.

Keyphrases

stem cell transplantation
high dose
stem cells
cardiovascular events
type diabetes
induced pluripotent stem cells
mesenchymal stem cells
respiratory syncytial virus
cell therapy